World Biological Drugs Market 2012-2022

Posted: Published on June 4th, 2012

This post was added by Dr P. Richardson

NEW YORK, June 4, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

World Biological Drugs Market 2012-2022

http://www.reportlinker.com/p0470101/World-Biological-Drugs-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Report Details

Your guide to biopharma industry trends and revenue prospects

Where is the market for biological drugs heading? Visiongain's report shows you potential revenues to 2022, with data, forecasts and discussions.

Our new study investigates biotechnology in pharma - biological drugs (biopharmaceuticals, biologics). It lets you assess potential sales trends at world market, submarket, product and regional level to 2022.

How will 20 leading biologics - including Avastin, Enbrel, Humira and Herceptin - perform from 2012? Our investigation gives you business research and analysis with sales forecasts.

You also see forecasting of submarkets to 2022, finding potential revenues:

Monoclonal antibodies (MAbs) and fusion proteins

Go here to read the rest:
World Biological Drugs Market 2012-2022

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.